ESR1 and neoplasm: CD133hi cells are enriched in tumours from HT-treated mice, which also have reduced ER expression (Fig. 1c and Supplementary Fig. 4c); we therefore hypothesized that reducing ER activity in differentiated cells (with tamoxifen) could convert CD133lo cells into CD133hi ones.